GleamWall
中文EN

TKNO Alpha Teknova, Inc.

In Vitro & In Vivo Diagnostic Substances · Nasdaq · SEC CIK 1850902 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY15.4%
TTM net income YoY12.3%
TTM EPS YoY9.1%
Revenue 3-yr CAGR7.8%
Net income 3-yr CAGR—

Margins

Gross margin36.4%
Operating margin-32.7%
Net margin-34.8%
FCF margin-13.9%
EBITDA margin-20.1%

Returns

ROE-24.1%
ROA-15.8%
ROIC (approx.)-15.9%
Asset turnover0.45x

Leverage & solvency

Liabilities / assets36.9%
Debt / equity0.22x
Current ratio3.56x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.35x
Accruals ratio-10.3%
Payout ratio—
Capex / revenue1.8%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$40.52M$37.74M
Cost of revenue$27.08M$30.51M
Gross profit$13.44M$7.23M
R&D expense$2.20M$2.76M
SG&A expense$20.32M$23.15M
Operating income-$16.98M-$26.15M
Pretax income-$17.20M-$26.83M
Income tax$58,000-$88,000
Net income-$17.26M-$26.75M
EBITDA-$10.63M-$19.57M
EPS (basic)-0.32-0.57
EPS (diluted)-0.32-0.57
Weighted avg. shares (diluted)53.48M46.75M
Banking
Net interest income-$710,000-$687,000
Balance sheet
Cash & equivalents$5.91M$3.71M
Short-term investments$15.43M$26.69M
Receivables$4.62M$4.31M
Inventory$7.05M$6.80M
Current assets$34.51M$42.78M
PP&E, net$41.73M$45.75M
Intangibles$11.94M$13.09M
Total assets$103.58M$118.77M
Current liabilities$7.54M$11.21M
Short-term debt$0$4.04M
Long-term debt$13.12M$9.44M
Total debt$13.12M$13.49M
Total liabilities$34.81M$36.38M
Shareholders' equity$68.78M$82.39M
Net debt$7.21M$9.78M
Shares outstanding53.56M53.41M
Cash flow statement
Operating cash flow-$8.65M-$12.39M
Capital expenditure$1.15M$1.12M
Free cash flow-$9.79M-$13.52M
Investing cash flow$10.70M-$27.27M
Financing cash flow$151,000$14.89M
Depreciation & amortization$6.34M$6.58M
Stock-based compensation$3.43M$3.67M

Free plan shows the latest 2 periods; Pro shows all 6 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.